Skip to main content

Haemodynamic and Antihypertensive Effect of Prostacyclin

  • Chapter
Thrombosis and Cardiovascular Disease

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 164))

Abstract

Prostacyclin (2) is a natural product of blood vessels, synthetized predominantly in endothelium and released in minute amounts into circulation (3). Besides its potent antiplatelet activity (1,4, 6), prostacyclin is also a powerful vasodilator. The vasodilating properties were noticed already during first administration of prostacyclin to man (7), and were subsequently studied in detail in 10 subjects without evidence of coronary heart disease or cardiac failure (11, 12). Prostacyclin was infused in three dose levels (2, 5 and 10 ng/kg/min) leading to following effects:

  1. 1)

    Distinct fall in peripheral and total pulmonary vascular resistances;

  2. 2)

    Drop in intra-arterial blood pressure;

  3. 3)

    Acceleration of the heart rate;

  4. 4)

    Increase in muscle blood flow;

  5. 5)

    Stroke volume, mean right atrial pressure and left ventricular end-diastolic pressure showed no significant changes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R.J. Gryglewski, Prostaglandins, platelets and atherosclerosis. CRC Series in Biochemistry 7: 291 (1980).

    Article  CAS  Google Scholar 

  2. R.J. Gryglewski, S. Bunting, S. Moncada, R.J. Flower, J.R. Vane, Arterial walls are protected against deposition of platelet thrombi by a substance (Prostaglandin X) which they make from prostaglandins endoperoxides. Prostaglandins 12: 685 (1976).

    Article  PubMed  CAS  Google Scholar 

  3. R.J. Gryglewski, R. Korbut, A. Ocetkiewicz, Generation of prostacyclin by lungs in vivo and its release into arterial circulation. Nature 273: 765 (1978).

    Article  PubMed  CAS  Google Scholar 

  4. R.J. Gryglewski, A. Szczeklik, R. Nizankowski, Anti-platelet action of intravenous prostacyclin in man. Thrombos. Res. 13: 153 (1978).

    Article  CAS  Google Scholar 

  5. A. Ollson, L.A. Carlson, Clinical, haemodynamic and metabolic effects of intraarterial infusion of prostaglandin E1 in patients with peripheral vascular disease. Adv. Prostagl. Thrombox. Res. 1: 429 (1976).

    Google Scholar 

  6. A. Szczeklik, R.J. Gryglewski, E. Nizankowska, R. Nizankowski, J. Musial, Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man. Prostaglandins, 16: 651 (1978).

    Article  CAS  Google Scholar 

  7. A. Szczeklik, R.J. Gryglewski, R. Nizankowski, J. Musial, R. Pieton, J. Murk, Circulatory and antiplatelet effects of intravenous prostacyclin in healthy men. Pharmacol. Res. Commun. 10: 545 (1978).

    Article  PubMed  CAS  Google Scholar 

  8. A. Szczeklik, R. Nizankowski, S. Skawinski, J. Szczeklik, P. Gluszko, R.J. Gryglewski, Succesful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet 1: 1111 (1979).

    Article  PubMed  CAS  Google Scholar 

  9. A. Szczeklik, J. Szczeklik, R. Nizankowski, P. Gluszko, Prostacyclin for unstable angina. N. Engl. J. Med. 303: 881 (1980).

    PubMed  CAS  Google Scholar 

  10. J. Szczeklik, J.S. Dubiel, M. Mysik, Z. Pyzik, R. Krol, R. Horzela, Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension. Br. Heart J. 40: 1397 (1978).

    Article  PubMed  CAS  Google Scholar 

  11. J. Szczeklik, A. Szczeklik, R. Nizankowski, Haemodynamic effects of prostacyclin in man. Adv. Prostagl. Thrombox. Res. 7: 769 (1980).

    CAS  Google Scholar 

  12. J. Szczeklik, A. Szczeklik, R. Nizankowski, Haemodynamic changes induced by prostayclin in man. Br. Heart J. 44: 254 (1980).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Szczeklik, A., Gryglewski, R.J., Szczeklik, J., Nizankowski, R. (1984). Haemodynamic and Antihypertensive Effect of Prostacyclin. In: Strano, A. (eds) Thrombosis and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 164. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8616-2_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8616-2_30

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8618-6

  • Online ISBN: 978-1-4684-8616-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics